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Abstract
Highly active antiretroviral therapy (HAART) can suppress HIV-1 replication and normalize the chronic immune activation
associated with infection, but restoration of naı ¨ve CD4
+ T cell populations is slow and usually incomplete for reasons that
have yet to be determined. We tested the hypothesis that damage to the lymphoid tissue (LT) fibroblastic reticular cell (FRC)
network contributes to naı ¨ve T cell loss in HIV-1 infection by restricting access to critical factors required for T cell survival.
We show that collagen deposition and progressive loss of the FRC network in LTs prior to treatment restrict both access to
and a major source of the survival factor interleukin-7 (IL-7). As a consequence, apoptosis within naı ¨ve T cell populations
increases significantly, resulting in progressive depletion of both naı ¨ve CD4
+ and CD8
+ T cell populations. We further show
that the extent of loss of the FRC network and collagen deposition predict the extent of restoration of the naı ¨ve T cell
population after 6 month of HAART, and that restoration of FRC networks correlates with the stage of disease at which the
therapy is initiated. Because restoration of the FRC network and reconstitution of naı ¨ve T cell populations are only optimal
when therapy is initiated in the early/acute stage of infection, our findings strongly suggest that HAART should be initiated
as soon as possible. Moreover, our findings also point to the potential use of adjunctive anti-fibrotic therapies to avert or
moderate the pathological consequences of LT fibrosis, thereby improving immune reconstitution.
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Introduction
The hallmark of HIV-1 infection, depletion of CD4
+ T cells, has
been largely attributed to direct mechanisms of infection and cell
death from viral replication or killing by virus-specific cytotoxic T-
lymphocytes (CTLs), and to indirect mechanisms such as increased
apoptosis accompanying chronic immune activation associated
with HIV-1 infections [1]. It is thus puzzling that if these were the
sole mechanisms responsible for CD4
+ T cell depletion, why 20%
of HIV-1 infected patients have no significant increase in their
peripheral blood CD4 count after initiation of HAART, since
treatment can suppress viral replication to undetectable levels and
normalize much of the chronic immune activation associated with
infection [2–3]. Moreover, even among patients with significant
increases in peripheral blood CD4
+ T cells, few reconstitute to
normal levels after years of HAART, and this incomplete immune
reconstitution is associated with significantly higher rates of
malignancy and other morbidities compared with HIV-uninfected
individuals [4–11].
The preferential depletion of naı ¨ve T cells in blood and
lymphoid tissues (LT) [3], where they mainly reside, also poses
particular difficulties for attributing depletion simply to direct
mechanisms of viral infection or indirect mechanisms of
activation-induced cell death (AICD), since (1) naı ¨ve CD4
+ T
cells are resistant to HIV-1 infection and (2) AICD should
primarily affect the activated effector and memory populations
[12–14]. Furthermore, the similar extent of depletion of not only
naı ¨ve CD4
+ T cells but also naı ¨ve CD8
+ T cells that are not
usually infected by HIV [15–16], suggests that there is a general
mechanism impacting naı ¨ve T cell populations unrelated to direct
infection.
The incomplete restoration of naı ¨ve T cell populations with
HAART also points to mechanisms in addition to AICD in
depletion of CD4
+ T cells, since suppression of this ‘‘drain’’ should
enable repopulation of naı ¨ve CD4
+ T cell populations by
thymopoiesis and homeostatic proliferation of existing naı ¨ve T
cells in secondary LT, but this does not happen many patients
[17–20]. Cumulative observations therefore suggest that there may
be additional mechanisms that impair the survival of naı ¨ve T cells,
thereby restricting immune reconstitution [1,3].
To account for the preferential loss of naı ¨ve T cells, and failure
of HAART to restore both naı ¨ve and memory populations by
thymopoesis and homeostatic proliferation, we have proposed a
damaged LT niche hypothesis in which collagen deposition
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access to survival factors such as interleukin-7 (IL-7). This results in
elevated levels of naı ¨ve T cell apoptosis [21–23] before treatment
and impairs the reconstitution of naı ¨ve T cells after treatment. We
recently showed in the SIV-rhesus macaque animal model that the
critical disruption in LT architecture caused by collagen
deposition and decreased access of T cells to survival factor IL-7
‘‘posted’’ on the FRC network was in fact associated with
increased apoptosis and depletion of both naı ¨ve CD4
+ and
CD8
+ T cells. We also showed that this mechanism is a
cooperative and cumulative vicious cycle in which the mutual
interdependencies for survival of naı ¨ve T cells on IL-7, and the
FRC network on lymphotoxin-beta (LT-b) supplied by the T cells,
perpetuate depletion of both T cells and the FRC network [24].
One implication of this model is that because the impact of LT
fibrosis on CD4
+ T cell depletion is progressive and cumulative,
initiating HAART in the early stages of infection should improve
immune reconstitution because there should be less collagen
deposition and loss of the FRC network at this stage. We tested
this hypothesis by examining LTs from HIV-1 infected individuals
at baseline and 6 months after initiating HAART in the acute, pre-
symptomatic and AIDS stages of infection. We first document the
same damaged LT niche mechanism described in the SIV-rhesus
macaque model of collagen deposition and loss of the FRC
network with depletion of naı ¨ve T cells through increased
apoptosis as a consequence of decreased access to IL-7. We then
show that the extent of loss of the FRC network and collagen
deposition predict the extent of inhibition of naı ¨ve T cell apoptosis
and restoration of the naı ¨ve T cell population in LT after 6 months
of HAART, and total CD4 T cell counts in peripheral blood after
12 months of HAART. Furthermore, we find that the extent of
restoration of FRC network after 6 months of HAART is highly
dependent on the stage of disease at which the therapy is initiated,
with greatest restoration only when HAART is initiated during the
early stage of infection. This directly correlates with optimal
inhibition of naı ¨ve T cell apoptosis and restoration of naı ¨ve T cells
in the patients receiving HAART during the early stage of
infection. This mechanism explains why initiation of HAART
during the early stage of infection is associated with more rapid
and complete CD4
+ T cell restoration, and thus strongly argues for
early initiation of HAART [25–26]. It also argues for a potential
use of adjunctive therapies such as anti-fibrotic therapy to avert
and/or revert the LT structure to improve immune reconstitution.
Results
Collagen deposition and loss of the FRC network impede
access to and source of IL-7 in HIV-1 infection
Toevaluatethishypothesis,wefirstshowthat theFRCnetworkis
the major source of IL-7 for T cells in human LTs, as has been
demonstrated in mice and monkeys [22,24]. In LT sections from
uninfected individuals stained for IL-7 and desmin, a marker for
FRCs, IL-7 largely co-localizes with the FRC network on which
lymphocytes, antigen presenting cells and other cells within LTs
migrate (Figure 1A). This architecture allows T cells to efficiently
access survival factors such as IL-7 and self-antigen-major
histocompatibility complex as well as chemokines ‘‘posted’’ on their
path.Thus, inthe lymph node (LN) sectionsfromHIV-1-uninfected
individuals stained for type I collagen, desmin and T cells, the
collagen within the FRC network co-localizes with desmin, and the
T cells visibly contact the FRC network (Figure 1B). In contrast,
HIV-1 infection is associated with stage-specific progressive
decreases in the FRC network (Figure 1D-E) and thus the available
source of IL-7 (Figure 1F). The depletion of FRCs correlates with a
parallel increase in collagen deposited outside the FRC network, so
that as infection progresses, fewer and fewer T cells are in contact
with and have access to IL-7 on the FRC network (Figure 1C)
compared with uninfected populations (Figure 1B).
T cell apoptosis increases with decreased availability of
IL-7
Because survival of naı ¨ve T cells is dependent on access to IL-7
[21–23], the collagen deposition-restricted access to and loss of the
FRC network itself should result in an increase in apoptosis
proportional to the extent of collagen depositionand decreased IL-7
source as infection progresses. We first demonstrate that contact
with FRCs as a source of IL-7 is critical for T cell survival in an ex
vivo culture system. We established monolayers of desmin
+ IL-7
+
FRC-like cells from stromal cells isolated from human tonsils
(Figure 2A–B), and show that IL-7 localizes to the surfaces of live
cells stained without permeabilization (Figure 2C). Only about 10%
of naı ¨ve T cells underwent apoptosis if co-cultured with autologous
IL-7
+ FRC-like cells compared to about 30–40% of naı ¨ve T cells
cultured for 2–3 days without stromal cells. We show that the
enhanced survival is contact dependent and is mediated mainly via
IL-7, as antibody blocking of IL-7 or separation of T cells and the
FRCs by transwells leads to increased apoptosis in naı ¨ve T cells
(Figure 2D–E). However, the blockade of IL-7 does not fully
recapitulate the apoptosis level in the naı ¨ve T alone culture,
suggesting that other survival factors such as CCL19 produced by
FRCs may independently support the survival of naı ¨ve T cells [22].
These ex vivo co-culture results support the concept that naı ¨ve
T cells need to contact FRCs in order to gain access to IL-7 to
maintain their survival. Therefore, the loss of FRCs as well as the
loss of the contact between naı ¨ve T cells and FRCs together in vivo
would be expected to increase apoptosis and thereby deplete naı ¨ve
T cells. We tested this hypothesis in LTs from HIV-1 infected
patients and found that the stage-dependent increases in naı ¨ve T
cell apoptosis (Figure 3A) were associated with depletion of both
naı ¨ve CD4
+ and CD8
+ T cells (Figure 3B–C), and that stage-
dependent decreases in the FRC network (Figure 1D) were
Author Summary
The hallmark of HIV-1 infection is depletion of CD4 T cells,
whose loss leads to the opportunistic infections and
cancers characteristic of AIDS. Highly active antiretroviral
therapy (HAART) can control HIV-1 replication, but
reconstitution particularly of naı ¨ve T cells is often
incomplete and slow. We show here that fibrosis damages
lymphoid tissues (LT), thereby contributing to depletion
and incomplete reconstitution. Prior to treatment, chronic
immune activation induces LT fibrosis to disrupt the
fibroblastic reticular cell (FRC) network, the major source of
the T cell survival factor interleukin 7 (IL-7). Fibrosis in this
way interferes with the access of T cells to IL-7 ‘‘posted’’ on
the FRC network. Without a source and access to IL-7,
naı ¨ve cells are depleted prior to initiating HAART because
of increased apoptosis, and, even after initiating HAART,
the losses continue by this mechanism because of pre-
existing LT damage. Thus, LT fibrosis impairs immune
reconstitution despite the beneficial effects of HAART in
suppressing viral replication. Because less LT damage has
accumulated in earlier stages of infection, early initiation of
HAART also improves immune reconstitution. This LT
damage mechanism also suggests that anti-fibrotic treat-
ment in addition to HAART could further improve immune
reconstitution.
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(Figure 3D–E).
Restoration of LT structure and increases in naı ¨ve T cells
depend on the timing of initiation of HAART
Because the LT damage-mediated naı ¨ve T cell depletion
mechanism now documented in both HIV-1 infection and SIV
infection [24] is cumulative and progressive, the later stage of
infection,the greaterthe damage toLTstructure.Thus,iftreatment
does not restore the LT structure that supports survival of naı ¨ve
CD4
+ T cells, theLT damage mediatednaı ¨ve T cell depletioncould
adversely affect immune reconstitution, even with suppression of
viral replication and immune activation by HAART. Conversely,
the lesser extent of LT damage in early infection could improve
immune reconstitution with HAART, if initiating treatment were to
restore LT structure and improve naı ¨ve T cell survival.
To test these predictions, we examined the effects of HAART
initiated in the acute/early, pre-symptomatic and AIDS stages of
infection on LT structure, naı ¨ve T cell apoptosis and restoration of
naı ¨ve CD4
+ T cell populations. Because loss of the FRC network
and fibrosis are less in the acute/early stage than at later stages of
HIV-1 infection (Figure 1), we would expect that the preservation
of LT structure in acute/early HIV-1 infection would result in
decreased apoptosis and greater increases in naı ¨ve T cells if
HAART is initiated at this stage. We indeed found that the loss of
the FRC network and collagen deposition prior to initiating
HAART are associated with significantly increased naı ¨ve T cell
apoptosis after 6 months of HAART (p=0.0016 and p=0.0292
respectively) (Figure 4A–B). Furthermore, the level of naı ¨ve T cell
apoptosis both before and after treatment is significantly associated
with fewer naı ¨ve T cells in LTs (p=0.0012). Taken together, these
data suggest the extent of LT damage is associated with the extent
of inhibition of naı ¨ve T cell apoptosis after HAART. We note that
this now documents in LTs the previously reported predictive
relationship between collagen in LTs and naı ¨ve CD4
+ T cell
increases in peripheral blood [27].
We also find that HAART initiated in the acute/early stage
infection results in the greatest restoration of FRCs after 6 months
Figure 1. Collagen deposition and loss of the FRC network impede access to and source of IL-7 in HIV-1 infection. A. FRCs are the
major producers of IL-7. LN sections (representative image for one HIV negative subject of 5) stained for desmin (red) and IL-7 (green). Merged
confocal image shows co-localization of IL-7 and FRCs in T cell area. Scale bar, 10 mm. B–C. Collagen deposition and loss of the FRC network disrupts
interaction between T cells and FRCs. Confocal images of LN sections from an uninfected subject (representative image for one subject of 5)
immunofluorescently stained for desmin (green), collagen (red) and CD3 (blue). The merged image shows that FRCs colocalize with collagen and T
cells are in contact with the FRC network (B). Confocal images of LN sections from a subject at AIDS stage (representative image for one subject of 6).
The merged image shows that the loss of FRCs and associated collagen deposition leads to loss of the contact between FRCs and T cells, which
instead contact mainly extra-FRC collagen. Scale bar, 20 mm (C). D. Confocal images of LN sections from HIV negative subjects and from subjects at
different stage of HIV infection immunofluorescently stained for desmin (green) and collagen (red), showing the gradual loss of FRCs in the T cell
zone within LTs, which is associated with extensive collagen deposition during HIV infection. Scale bar, 20 mm. E. Quantification of average amount of
FRCs and collagen deposition at each stage of infection, showing the gradual loss of FRCs and collagen deposition. Error bars represent the s.d. F.
Confocal images of LN sections from HIV negative subjects and from subjects at different stage of HIV infection immunofluorescently stained for IL-7
(green), showing that the gradual loss of IL-7 in the T cell zone is associated with gradual depletion of FRCs (E). Scale bar, 20 mm.
doi:10.1371/journal.ppat.1002437.g001
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(Figure 5A–B). The restoration of LT structure is a slow process as
even after 36 months of HAART the area occupied by the FRC
network increases but still remains significantly less than in HIV-1
uninfected individuals. Minimal recovery of the FRC network is
seen in HIV-1 infected patients starting HAART at chronic stages
(Figure 5A). At 6 months, there is no significant effect on removal
of collagen deposition in LTs (Figure 5A–B), but there is increased
collagen co-localizing with the FRC network, as opposed to
collagen deposits outside the network, albeit not to the same levels
seen in HIV-1 uninfected individuals where 90 percent of collagen
is within the FRC network (Figure 5C-D). We further found that
the new WHO guidelines for initiating HAART at CD4 counts of
350 cells/ml have a sound rationale in preservation of the FRC
network, since only when therapy had been initiated at or above
350 cells/ml could we detect significant improvement of FRCs
after 6-month HAART (Figure S1).
HAART initiated in acute/early stage of infection is also
associated with greatest decreases in apoptosis and optimal
restoration of naı ¨ve T cell populations in LTs (Figure 6). In
contrast, naı ¨ve T cell numbers in patients who initiated HAART
in the AIDS stage of infection did not increase significantly, and
apoptosis in naı ¨ve T cell populations remained high (Figure 6).
These stage-related correlations apply as well to peripheral CD4
+
T cell counts in patients receiving HAART for 12 months. The
increase in peripheral CD4
+ T cell counts to the level of counts in
HIV-1 uninfected individuals depended on initiating HAART
during the acute/early stage of infection (Figure S2A). We also
found that this stage-dependent restoration of peripheral CD4
+ T
cells can be predicted by the extent of fibrosis before initiation of
HAART, again suggesting that fibrosis is one key factor that limits
immune reconstitution after long-term HAART (Figure S2B).
We also assessed the relationships between viral load and the
residual Ki67 level to the extent of restoration of naı ¨ve T cells
Figure 2. Naı ¨ve T cells need to contact FRCs to get access to IL-7 for survival. (A–C) IL-7 is produced and presented on the surface of
stromal cells. A-B. Confocal images of monolayer of fixed and permeablized stromal cells isolated from human tonsil immunofluorescently stained for
(A) IL-7 (green) or (B) desmin (green) and DAPI (blue) at one-day post passage. Scale bar, 30 mm. C. Confocal image of live stromal cells (DAPI: blue)
staining showing the IL-7 (green) on the surface of stromal cells. Scale bar, 10 mm. D-E. FRC-like stromal cells enhance the survival of naı ¨ve T cells via
IL-7. D. Triple fluorescently stained activated caspase 3
+ (green), CD45RA
+ (red) and CD3
+ (blue) cells in an ex vivo culture system showing that
stromal cells enhance the survival of naı ¨ve T cell by mechanisms dependent on IL-7 and cell contact. 2x10
5 lymphocytes from human tonsil were
cultured with or without stromal cells for 2–3 days. Naı ¨ve T cell apoptosis is reduced in co-cultures with stromal cells (+ stromal cells) compared to
cultures without stromal cells. Apoptosis in the naı ¨ve T cell population increases with IL-7 blocking antibody (anti-IL-7) or when lymphocytes are
separated from stromal cells by a transwell filter (Filter) compared to co-cultures with stromal cells. Scale bar, 60 mm. E. Quantification of the
percentages of activated caspase 3
+CD45RA
+CD3
+ naı ¨ve T cells in total T cell population at day 2 and day 3 cultures. Values are the mean of the
percent apoptotic naı ¨ve T cells 6 s.d. ANOVA comparison was done on the average percentages of day 2 and day 3.
doi:10.1371/journal.ppat.1002437.g002
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increases in naı ¨ve T cells and decreases in apoptosis do not
correlate with HAART-mediated suppression of viral replication
and immune activation. HAART initiated at all stages of infection
can potently and comparably inhibit viral replication and
associated chronic immune activation (Figure 7A and B). There
is therefore no evidence that these processes are playing important
roles in the stage-specific effects of time of initiation on apoptosis
and recovery of naı ¨ve T cells within LTs. We in fact found no
significant association between viral load and the number of naı ¨ve
T cells or the number of apoptotic naı ¨ve T cells, nor any
association between activation represented by the number of
Ki67
+ cells and the number of naı ¨ve T cells or the number of
apoptotic naı ¨ve T cells after 6 month HAART (Figure 7C–F).
Discussion
It has generally been thought that viral and immune-cell
mediated killing of CD4
+ T cells and AICD accompanying
chronic immune activation are respectively the major direct and
indirect mechanisms of CD4
+ depletion in HIV-1 infection, and
that the slow and incomplete restoration of naı ¨ve CD4
+ T cells is a
consequence of the restricted capacity of the adult thymus to re-
supply naive T cells [1]. Here we describe a novel mechanism that
depletes CD4
+ T cells, particularly naı ¨ve CD4
+ T cells before
HAART and determines the pace and extent of naı ¨ve CD4
+ T cell
restoration after HAART.
Naı ¨ve T cells depend on IL-7 produced and presented by the
FRC network for survival. Our IL-7 staining is consistent with a
large literature on the FRC network as the site and source of most
of the IL-7 [22,24,28–29], although different from one report on
human IL-7 staining in LTs [30], probably due to different
reagents and methodologies used. As HIV-1 infection advances,
collagen deposition increases and the FRC network is destroyed,
which decreases the amount of IL-7 available to support T cell
survival. As a consequence, increased apoptosis depletes naı ¨ve T
cells prior to HAART in proportion to the progressive destruction
of LT structure from early to later stages of HIV-1 infection.
Figure 3. Loss of FRCs is associated with loss of naı ¨ve T cells within LTs. A. Confocal images of LN sections from subjects at different stage of
HIV infection triple immunofluorescently stained for TUNEL (green), CD45RA (red) and CD3 (Blue), showing the gradual loss of CD45RA
+CD3
+ naı ¨ve T
cells is associated increased apoptosis in the naı ¨ve T cell population within LTs during HIV infection. Scale bar, 10 mm. B. Confocal images of LN
sections from subjects at different time points post HIV infection double immunofluorescently stained for CD45RA (green) and CD4 or CD8 (red),
showing both naı ¨ve CD4 and CD8 T cells are depleted within LTs. Scale bar, 20 mm. C. Quantitative image analysis of the number of apoptotic naı ¨ve T
cells and the number of naı ¨ve T cells (CD45RA
+CD3
+), showing that increased apoptosis in the naı ¨ve T cell population is associated with depletion of
naı ¨ve T cells (total n=37, p,0.0001, R
2=0.5373). D. Quantification of FRCs (the percent area staining positive for desmin in T cell zone) and the
number of apoptotic naı ¨ve T cells (TUNEL
+CD45RA
+CD3
+), showing that the depletion of FRCs is associated with increased apoptosis in naı ¨ve T cell
populations (total n=37, p,0.0001, R
2=0.5843). E. Quantitative image analysis of FRCs and the number of naı ¨ve T cells within LTs, showing that the
loss of naı ¨ve T cells is associated with loss of FRCs (total n=37, p,0.0001, R
2=0.5166). Values are the mean of measurement 6 s.d.
doi:10.1371/journal.ppat.1002437.g003
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PLoS Pathogens | www.plospathogens.org 5 January 2012 | Volume 8 | Issue 1 | e1002437Figure 4. The extent of LT destruction before HAART predicts the extent of restoration of naı ¨ve T cells after HAART. A. The area that
FRCs occupy before HAART is negatively associated with the number of apoptotic naı ¨ve T cells after 6 months of HAART. B. The collagen area before
HAART is positively associated with the number of apoptotic naı ¨ve T cells after 6 months of HAART.
doi:10.1371/journal.ppat.1002437.g004
Figure 5. Restoration of LT structure is slow and incomplete after HAART and is associated with the timing of initiation of HAART. A.
Representative confocal images of immunofluorescent staining for desmin (green) and collagen (red), showing the different extent of restoration of
stromal cell network and collagen normalization after 6 months of HAART. Scale bar, 20 mm. B. Quantification of the average area of FRCs and
Lymphoid Tissue Damage in HIV Infection
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pathological process, apoptosis of naı ¨ve T cells continues at
elevated levels after HAART has been initiated, even though
HAART can potently suppress viral replication and at least
partially normalize immune activation. The elevated apoptosis
level in naı ¨ve T cell populations is in proportion to pre-existing
damage to LT structure, which is greater in the chronic stages of
infection. Thus, predictably, early treatment results in better
preservation and restoration of LT structure, which leads to
improved survival of naı ¨ve T cells and greater increases in naı ¨ve T
cell numbers. While the limited capacity of the thymus in the adult
to supply naı ¨ve T cells will certainly limit the pace and extent of
reconstitution, the LT structure to which thymic emigrants home
thus also determines their subsequent survival. By analogy to
earlier tap-and-drain models [31], restoration of naı ¨ve T cells will
be dependent not only on thymic output and from homeostatic
proliferation of naı ¨ve T cell populations in LT, but also on the
drain of overall apoptosis in this population. In such a model, the
elevated level of apoptosis in naı ¨ve T cells in secondary LTs limits
both the extent and pace of immune reconstitution.
As the diversity of the naı ¨ve T cell repertoire is critical to defend
against new infections and malignancies, the loss and slow
restoration of the naı ¨ve T cell population creates ‘‘holes’’ in the
T cell repertoire and therefore impairs host defenses even after
collagen before and after 6 months of HAART in patients receiving the HAART at different stages of infection, showing the different extent of
restoration of LTs is associated with the timing of initiation of HAART. Error bars represent the s.d. C. Representative confocal images of
immunofluorescent staining for desmin (green) and collagen (red), showing that the different extent of restoration of the FRC network and collagen
normalization after 6 months of HAART as represented by the percent area not covered by FRCs. Scale bar, 20 mm. D. Quantification of the percent
area covered by FRCs.
doi:10.1371/journal.ppat.1002437.g005
Figure 6. Incomplete LT restoration is associated with high level of apoptosis in naı ¨ve T cell populations and incomplete
restoration of naı ¨ve T cells. A. Confocal images of LN sections from uninfected subjects and patients receiving 6 months of HAART at either acute
or AIDS phase of infection, immunofluorescently stained for CD45RA (red) and CD3 (blue), showing the different extent of restoration of naı ¨ve T cells.
Scale bar, 10 mm. B. Quantification of number of naı ¨ve T cells before and after HAART at each stage of infection, showing the different kinetics of
restoration of naı ¨ve T cells. Error bars represent the s.d. C. Confocal images of LN sections from patients receiving 6 months of HAART at either acute
or AIDS phase of infection immunofluorescently stained for CD45RA (red), CD3 (blue) and TUNEL staining of apoptotic cells (green), showing the
higher level of apoptosis in naı ¨ve T cell populations after 6 months of HAART when HAART was started during chronic phase of infection. Scale bar,
10 mm. D. Quantification of average number of apoptotic naı ¨ve T cells before and after HAART at each stage of infection, showing the different
kinetics of decrease of apoptotic naı ¨ve T cells.
doi:10.1371/journal.ppat.1002437.g006
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therapeutic approaches to prevent or moderate damage to the LT
niche and restore a functional FRC network could be particularly
beneficial in increasing and preserving naı ¨ve T cell populations
after HAART. The most straightforward way to do this is through
earlier treatment. Our findings also suggest the potential clinical
benefit of complementing IL-7 treatment during HIV-1 infection
in the restoration of naı ¨ve T cell population. Indeed, studies have
shown that complementing HAART with IL-7 during both SIV
and HIV infection significantly increases the circulating naı ¨ve
CD4
+ T cell number [32–34]. Furthermore, it has been shown
that IL-7 treatment could normalize the extent of apoptosis in
CD4
+ and CD8
+ T cells from HIV-1-infected individuals via
up-regulation of Bcl-2 levels [35–36]. These data consistently
suggest that insufficient IL-7 is a key contributor in the impaired T
cell homeostasis in SIV/HIV infection and limits the reconstitu-
tion of T cells.
However, the immediate decline of the absolute numbers of
both naı ¨ve CD4
+ and CD8
+ T cells after termination of IL-7
therapy [32–34] suggests that complementing IL-7 only provides
transient survival benefit for naı ¨ve CD4 and CD8 T cells and
strongly argues for the development of therapeutic interventions to
provide long-term survival benefit for naı ¨ve T cells through
preservation or restoration of the FRC network where naı ¨ve cells
can access IL-7. Our findings here clearly suggest that collagen
deposition and the consequential loss of FRCs as the major source
of IL-7 play critical roles in compromising homeostasis of naı ¨ve T
cells. Therefore, the restoration of the lymphoid tissue niche could
potentially provide long-term survival benefits for naı ¨ve T cells.
Moreover, the development of adjunctive anti-fibrosis treatment
such as pirfenidone and losartan [24,37–42] might additionally
avert or revert the consequences of damage to the LT niche and
improve immune reconstitution.
Materials and Methods
Ethics statement
This human study was conducted according to the principles
expressed in the Declaration of Helsinki. The study was approved
by the Institutional Review Board of the University of Minnesota.
All patients provided written informed consent for the collection of
samples and subsequent analysis.
Figure 7. The extent of restoration of naı ¨ve T cells after HAART is not associated with viral load or immune activation. A. Viral load
before and after HAART in patients receiving HAART at different stages of infection, showing the inhibition of viral replication is similar for patients at
different stage of infection. B. Quantification of the number of Ki67
+ cells before and after HAART in patients receiving HAART at different stages of
infection, showing the inhibition of immune activation by HAART is similar for patients at different stage of infection (ns, not significant). C, E.
Association between the viral load and number of naı ¨ve T cells and association between viral load and the number of apoptotic naı ¨ve T cells after
HAART are not significant. D, F. Association between the number of Ki67
+ cells and naı ¨ve T cells and association between the number of Ki67
+ cells
and the number of apoptotic naı ¨ve T cells after HAART are not significant.
doi:10.1371/journal.ppat.1002437.g007
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Patient
Disease
Stage
Time after
HAART Race Gender Age
Peripheral Blood
CD4
+ T Cell Count
(Cells/ml)
Plasma HIV-1
RNA Levels
(Copies/ml)
Opportunistic
Infections (n =
none reported)
1292 Uninfected N/A Caucasian Male 28 925 Undetectable N/A
1476 Uninfected N/A Caucasian Female 28 704 Undetectable N/A
1472 Uninfected N/A Caucasian Female 52 837 Undetectable N/A
1425 Uninfected N/A Caucasian Male 43 1351 Undetectable N/A
1442 Uninfected N/A Caucasian Female 45 1124 Undetectable N/A
1430 Acute D0 Caucasian Male 26 683 3610 n
1430 Acute M6 702 17400
1458 Acute D0 Caucasian Male 51 400 439000 n
1458 Acute M6 671 ,50
1329 Acute D0 Caucasian Male 59 370 484694 n
1329 Acute M6 871 ,50
1329 Acute M36 789 ,50
1469 Acute D0 Caucasian Male 44 180 .100,000 n
1469 Acute M6 321 7547
1449 Acute D0 Caucasian Male 30 333 .100000 n
1435 Acute D0 Caucasian Male 42 410 .100,000 Unknown
1435 Acute M6 663 ,50
1391 Acute D0 Black or African
American
Male 37 414 24718 n
1391 Acute M6 765 ,50
1437 AIDS D0 Caucasian Male 47 214 656 n
1437 AIDS M6 235 ,50
1438 AIDS D0 Caucasian 49 147 4960 n
1438 AIDS M6 151 ,50
1438 AIDS M36 216 ,50
1406 AIDS D0 Black or African
American
Male 45 188 10684 n
1406 AIDS M6 209 11438
1413 AIDS D0 Black or African
American
Male 50 42 59401 Unknown
1413 AIDS M6 121 8
1462 AIDS M6 143 ,50 n
1327 AIDS D0 Black or African
American
Female 40 112 12046 n
1327 AIDS M6 180 14
1419 AIDS D0 Caucasian Male 37 157 61432 n
1419 AIDS M6 320 79
1463 Pre D0 Black or African
American
Male 23 259 27200 n
1463 Pre M6 599 ,50
1447 Pre D0 Caucasian Male 37 640 12100 Unknown
1447 Pre M6 776 24300
1468 Pre D0 Caucasian Male 30 875 2150 n
1335 Pre D0 Caucasian Male 32 400 15284 n
1335 Pre M36 458 ,50
1428 Pre D0 Caucasian Male 30 363 38600 Unknown
1428 Pre M6 379 ,50
1479 Pre D0 Caucasian Male 42 273 1650 n
1479 Pre M6 479 ,75
1464 Pre D0 Caucasian Male 34 202 122000 n
1464 Pre M6 450 72
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Inguinal LN (LN) biopsies from HIV negative individuals and
HIV-1-infected individuals at different clinical stages (7 at acute/
early stage, 18 at presymptomatic stage and 8 at AIDS stage.
Table 1)wereobtainedforthis University ofMinnesotaInstitutional
Review Board-approved study. Viral load measurements were
obtained thesamedayasbiopsies.Each LNbiopsywas immediately
placed in fixative (4% neutral buffered paraformaldehyde or
Streck’s tissue fixative) and paraffin embedded.
Immunofluorescence staining and Quantitative Image
Analysis (QIA)
All staining procedures were performed as previously described
[24,43] using 5–30 mm tissue sections mounted on glass slides.
Tissues were deparaffinized and rehydrated in deionized water.
Heat-induced epitope retrieval was performed using a high-
pressure cooker (125uC) in either DIVA Decloaker or EDTA
Decloaker (Biocare Medical), followed by cooling to room
temperature. Tissues for collagen type I staining required pre-
treatment with 20 mg/ml proteinase K (Roche Diagnostics) in
proteinase K buffer (0.2 M Tris, pH 7.4, 20 mM CaCl2) for 15–
20 min at room temperature. Tissue sections were then blocked
with SNIPER Blocking Reagent (Biocare Medical) for 30 min at
room temperature. Primary antibodies were diluted in TNB
(0.1M Tris-HCl, pH 7.5; 0.15 M NaCl; 0.05% Tween 20 with
Dupont blocking buffer) and incubated overnight at 4uC. After
the primary antibody incubation, sections were washed with
phosphate buffered saline (PBS) and then incubated with
fluorochrome-conjugated secondary antibodies in TNB for 2 hr
at room temperature. Finally, sections were washed with PBS,
nuclei were counterstained blue with DAPI, and mounted using
Aqua Poly/Mount (Polysciences Inc.). Immunofluorescent mi-
crographs were taken using an Olympus BX61 Fluoview confocal
microscope with the following objectives: x20 (0.75 NA), x40
(0.75 NA), and x60 (1.42 NA); images were acquired and mean
fluorescence intensities were analyzed using Olympus Fluoview
software (version 1.7a).
Isotype-matched negative control antibodies in all instances
yielded negative staining results (see Table 2, which lists the
primary antibodies and antigen retrieval methodologies).
Quantitative image analysis (QIA) was performed using 10–20
randomly acquired, high-powered images (X200 or X400
magnification) by either manually counting the cells in each
image or by determining the percentage of LT area occupied by
positive fluorescence signal using an automated action program in
Adobe Photoshop CS with tools from Reindeer Graphics.
Patient
Disease
Stage
Time after
HAART Race Gender Age
Peripheral Blood
CD4
+ T Cell Count
(Cells/ml)
Plasma HIV-1
RNA Levels
(Copies/ml)
Opportunistic
Infections (n =
none reported)
1669 Pre D0 Caucasian Male 23 434 6506 n
1669 Pre M6 524 85
1293 Pre D0 Caucasian Male 36 905 14225 Unknown
1293 Pre M6 1842 ,50
1293 Pre M36 2251 ,50
1408 Pre D0 Caucasian Male 39 685 20014 n
1408 Pre M6 592 9815
1680 Pre M6 Caucasian Male 38 539 ,48 n
1448 Pre D0 Black or African
American
Male 51 543 10000 Unknown
1448 Pre M6 335 2790
1727 Pre D0 Caucasian Male 39 336 17600 n
1436 Pre D0 Caucasian Male 63 248 46400 n
1436 Pre M6 297 893
1407 Pre D0 Caucasian Male 35 372 31922 n
1407 Pre M6 353 108996
1679 Pre D0 Caucasian Male 36 620 17388 n
1679 Pre M6 721 ,48
1317 Pre D0 Caucasian Male 31 399 120469 n
1317 Pre M6 779 303
1766 Pre D0 Black or African
American
Male 36 389 6810 n
1455 Pre D0 Black or African
American
Male 23 209 19400 n
1455 Pre M6 324 ,50
1459 Pre D0 Caucasian Male 36 286 .100000 n
Note: Definition of classification of HIV infection stage: Acute/Early stage: patients are RNA
+ and antibody negative or have serologic proof of infection within the
previous 4 months. AIDS stage: patients whose CD4 count is ,200cells/mL. Presymptomatic stage: patients between acute/early stage and AIDS stage.
doi:10.1371/journal.ppat.1002437.t001
Table 1. Cont.
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The experimental protocols used here for human tissue samples
had full IRB approval (Institutional Review Board: Human
Subjects Committee, Research Subjects’ Protection Program,
University of Minnesota) and informed written consent was
obtained from individual patients, or the legal guardians of minors,
for the use of tissue in research applications prior to the initiation of
surgery. Fresh human palatine tonsil tissues were obtained from
routine tonsillectomies and processed within 1–2 h of completion of
surgery. Viable tonsil lymphocyte suspensions were prepared by
forcing cut tissue pieces through a metal sieve and collecting the
released single cell suspension in complete RPMI medium (10%
heat inactivated fetal calf serum, 1x l-glutamine, penicillin, and
streptomycin solution; Invitrogen). The cells were washed and
immediately cryopreserved. By culturing the stroma left on the
metal sieve in complete RPMI medium, adherent proliferating
fibroblasts were first visible after 2–5 days in culture, and confluent
monolayers developed after 10–25 days. These primary stromal
populations were readily released with trypsin, and the cells were
further expanded and passaged using routine procedures for
adherent cells. Some stromal cells were fixed in Streck’s tissue
fixative at one day prior to co-culture for analysis of intracellular
desmin and IL-7 expression. For live stromal cells staining and
imaging, stromal cells were directly incubated withantibody against
IL-7 at 4uC without heat antigen retrieval and subject to secondary
fluorochrome-conjugated-antibody staining. For co-culture of
lymphocytes and stromal cells, 2610
5 lymphocytes isolated from
human tonsil were cultured in chamber slides without stromal cells,
with autologous stromal cells (2610
4cells/well), with stromal cells
and IL-7 blocking antibody or with stromal cells but separated by
transwells for 2 to 3 days. After co-culture, the slides were fixed in
Streck’s tissue fixative and stained for activated caspase3, CD45RA
and CD3 to quantify the number of apoptotic naı ¨ve T cells by QIA
as described above.
Statistical analysis
To test for differences in FRCs and collagen across all stages a
1-way ANOVA was used and post-hoc comparisons were made
with Welch’s modified 2 sample t-tests with a Bonferroni
correction (hence p-values are reported for differences between
stages). A similar analysis was used to test for differences from the
data that arose from the ex vivo culture system.
To test for associations between FRCs and apoptotic naı ¨ve cell
counts mixed models were used with FRCs as the explanatory
variable in addition to clinical stage of infection (since it is
associated with both FRCs and apoptotic naı ¨ve cell counts).
Random effects were included in these models since all of the data
(i.e. all time points) were used to fit these models and random
effects provide a simple way to incorporate correlation among
measurements from the same subject into the model. Continuous
variables were log transformed prior to fitting the model and
restricted maximum likelihood was used to obtain parameter
Table 2. List of primary antibodies and antigen retrieval methodologies.
Antibody Clone/Manufacturer & Catalog # Antigen-retrieval Pretreatment Antibody Dilution Species
Desmin D33/Lab Vision & # MS-376-S1 Diva Decloaker; High pressure
cooker for 30 seconds at 125uC.
1/200 Mouse
Desmin Polyclonal/Lab Vision & # RB-9014-P1 Diva Decloaker; High pressure
cooker for 30 seconds at 125uC.
1/200 Rabbit
CD3 MCA147/AbD Serotec & # MCA1477 Diva Decloaker; High pressure
cooker for 30 seconds at 125uC.
1/200 Rat
CD3 SP7/Thermo Scientific & # RM-9107-S1 Diva Decloaker; High pressure
cooker for 30 seconds at 125uC.
1/100 Rabbit
IL-7 7417/R & D Systems & # MAB207 Diva Decloaker; High pressure
cooker for 30 seconds at 125uC.
Proteinase K treatment for 15 min
1/100 Mouse
CD45RA 4KB5/Dako & # M0754 Diva Decloaker; High pressure
cooker for 30 seconds at 125uC.
1/100 Mouse
Activated
Caspase-3
8G10/Cell Signaling Tech. & # 9665 1mm EDTA (ph 8); High pressure
cooker for 30 seconds at 125uC.
1/100 Rabbit
Collagen 1 COL-1/Sigma & # C2456 Diva Decloaker; High pressure cooker
for 30 seconds at 125uC. Protease K (10 mg/ml).
1/100 Mouse
Collagen I Polyclonal/Abcam & # ab292 Diva Decloaker; High pressure cooker for
30 seconds at 125uC. Protease K (10 mg/ml).
1/200 Rabbit
CD4 Polyclonal/R & D Systems & # AF-379-NA Diva Decloaker; High pressure cooker for
30 seconds at 125uC.
1/100 Goat
CD4 1F6/Novacastra & # NCL-CD4–1F6 Diva Decloaker; High pressure cooker for
30 seconds at 125uC.
1/100 Mouse
CD8 SP16/Neomarkers & # RM-9116-s Diva Decloaker; High pressure cooker for
30 seconds at 125uC.
1/100 Rabbit
Ki-67 SP6/Neomarkers & # RM-9106-S1 Diva Decloaker; High pressure cooker for
30 seconds at 125uC.
1/200 Rabbit
IgG Isotype
Controls
Dako, Jackson ImmunoResearch Diva Decloaker; High pressure cooker for
30 seconds at 125uC. Protease K (10 mg/ml).
1/50-1/200 Mouse, Rabbit,
Rat, Goat
A list of ID numbers for genes and proteins used in the paper: Desmin: 1674, CD3: 916, Interleukin-7: 3574, CD45RA: 151460, Caspase3: 600636, Collagen Type I: 120150,
CD4: 186940, CD8: 925, Ki-67: 176741.
doi:10.1371/journal.ppat.1002437.t002
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between apoptotic naı ¨ve cell counts and naı ¨ve counts. A similar
approach was used to test for an association between both Ki67
levels and viral load and apoptotic naı ¨ve cell counts and naı ¨ve
counts except that FRCs and collagen were included in the model
in addition to clinical stage of infection.
To test if baseline FRCs or collagen are predictive of apoptotic
naı ¨ve cell counts and naı ¨ve counts at 6 months post initiation of
HAART, linear regression models were used that included the
baseline value of the variable we were trying to predict at 6 months
since such baseline values are potentially related to the value of the
variable at 6 months and the baseline levels of FRCs or collagen.
All continuous variables were first log transformed and standard
model diagnostics were conducted.
One sample t-tests were used to test for changes over the first 6
months of therapy for each stage. Spearman’s rank correlation was
used to test for associations that were potentially nonlinear (but
monotone).
Supporting Information
Figure S1 Significant restoration of FRCs is associated
with early initiation of HAART. Bar plot shows that the
increase of FRCs is significant when HAART is initiated when
peripheral CD4
+ T cells is above 350 cells/ml. In contrast to that,
the increase of FRCs is insignificant when HAART is started when
peripheral CD4
+ T cells is below 350 cells/ml (*, p,0.05; ns, not
significant).
(TIF)
Figure S2 Incomplete restoration of peripheral CD4
count after 12 month HAART is associated with
initiation of HAART during chronic stage of infection.
A. Plot shows that the level of peripheral CD4 count is not
significantly different from that in uninfected subjects when
HAART is initiated during acute/early stage of infection after
12 month HAART. In contrast to that, when HAART is started
during chronic stage of infection, the level of peripheral CD4
count is still significantly lower than that in uninfected subjects
after 12 month HAART (*, p,0.05; **, p,0.01; ***, p,0.0001;
ns, not significant). B. The percent area of collagen before
HAART is negatively associated with the number of peripheral
CD4 count after 12 months of HAART.
(TIF)
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